SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001827506-24-000054
Filing Date
2024-06-07
Accepted
2024-06-07 16:02:56
Documents
1
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1717790566.html 4  
1 FORM 4 wk-form4_1717790566.xml 4 3940
  Complete submission text file 0001827506-24-000054.txt   5559
Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Issuer) CIK: 0001827506 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O CENTESSA PHARMACEUTICALS PLC D. HODGKIN BLDG, BABRAHAM RSRCH CAMPUS CAMBRIDGE X0 CB22 3FH
Business Address
KANTOFF AARON (Reporting) CIK: 0001862734 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40384 | Film No.: 241029203